Zimigut 200MG Tab

Tablet

Treatment of intestinal bacterial infections such as acute infectious diarrhoea (including traveller’s diarrhoea) caused by susceptible bacteria; may be used for other gut bacterial overgrowth conditions as prescribed.

Rifaximin is a minimally absorbed antibiotic that acts locally in the intestine. It inhibits bacterial RNA synthesis by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase, reducing the growth of susceptible gut bacteria.

Take the tablet by mouth with water, with or without food, exactly as prescribed. Complete the full course even if you feel better; do not self-treat persistent diarrhoea beyond 48 hours without medical advice.

Nausea, abdominal pain, flatulence, constipation, headache, dizziness

Do not use if allergic to rifaximin/rifamycins. Seek medical help if diarrhoea is severe, persistent, or accompanied by fever or blood in stools. Use with caution in severe liver disease; risk of adverse effects may be higher. Prolonged use may lead to superinfection including C. difficile–associated diarrhoea. Not recommended for children unless prescribed.

Warfarin (INR changes), cyclosporine (may increase rifaximin exposure), other anticoagulants/antiplatelets (monitor bleeding risk if INR changes), P-glycoprotein inhibitors (may increase levels)

Store below 25°C in a dry place, protected from moisture and light. Keep out of reach of children.

Rifagut 200 Tablet, Rifax 200 Tablet, Rifaxig 200 Tablet, Rifaximin 200 mg Tablet (generic), Rifax 200 mg Tablet